Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide with Chemoradiotherapy in Esophageal Cancer
NCT01551641Phase 2Unknown
- Sponsor
- Changzhou Second People's Hospital
- Start
- Jan 2012
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in esophageal cancer, sponsored by Changzhou Second People's Hospital. Status: unknown.
02
Drugs
thalidomide
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT01551641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01551641.